Highlights
A collection of news and information related to Allergan Inc. published by this site and its partners.
Displaying items 1-12 of 101
» View courant.com items only
1
2
3
4
5
6
7
8
9
•
Next >
-
Doctor linked to 1-800-GET-THIN faces medical board action
One of the brothers behind the 1-800-GET-THIN ad campaign for weight-loss surgery faces the possible revocation of his medical license in a misconduct case filed by state regulators. The Medical Board of California accused Michael Omidi of "repeated...
Tags: Crime, Law and Justice, Justice System, Surgery, University of California, Irvine, Breast Reduction
-
Gastric banding: Pros and cons of Christie's surprising choice
ReutersBy Sharon Begley and Ransdell Pierson May 7 (Reuters) - New Jersey Governor Chris Christie's choice of gastric banding has prompted questions about why he opted for a weight-loss procedure less favored by bariatric surgeons and patients. Lap-Band...Tags: Weight, Botox (drug), Health Insurance, Diabetes, Obesity
-
U.S. RESEARCH ROUNDUP: MasterCard, Visa, Facebook, Las Vegas Sands
ReutersMay 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Visa and Facebook, on Thursday. HIGHLIGHTS * MasterCard Inc : Nomura cuts target price to $593 from $611; rating buy * DXP...Tags: Weight, Green Plains Renewable Energy Incorporated, Manufacturing and Engineering, NII Holdings Incorporated, Cigna Corporation
-
The day ahead in business May 1
Reports: MBA mortgage index for week ended April 27, 6 a.m.; ADP employment change for April, 7:15 a.m.; PMI manufacturing index for April, 7:58 a.m.; ISM manufacturing index for April, 9 a.m.; Construction spending for March, 9 a.m.; Crude inventories...
Tags: Facebook, Enbridge Energy Partners LP, Comcast Corporation, Delphi Corp, Exelon Corp.
-
Strong Botox sales boost Allergan profit
ReutersMay 1 (Reuters) - Allergan Inc, maker of the Botox anti-wrinkle treatment, posted a stronger-than-expected quarterly profit, helped by strong sales of its eye-care drugs and Botox, which was recently also approved for treating migraine headaches. Net...Tags: Thomson Corporation, Drugs and Medicines, Botox (drug), Migraine
-
BRIEF-Allergan resumes trading down 11.5 percent after company says phase 2 eye drug data does not support directly moving to phase 3
ReutersNEW YORK, May 1 (Reuters) - Allergan Inc : * Resumes trading down 11.5 percent after company says phase 2 Darpin eye drug data does not support directly moving to phase 3 -
BRIEF-Regeneron Pharma shares resume trading, up 16 percent
ReutersNEW YORK, May 1 (Reuters) - Regeneron Pharmaceuticals Inc : * Shares resume trading, up 16 percent * Shares as shares of Allergan slide after co says vision drug approval likely delayed * Shares up 13.2 percent as shares of Allergan slide after co...Tags: Regeneron Pharmaceuticals Incorporated
-
FDA staff says Allergan's new dermal filler effective
ReutersApril 30 (Reuters) - Reviewers for the U.S. Food and Drug Administration said Allergan Inc's dermal filler, Juvéderm Voluma XC, was effective in correcting volume deficit in the middle of the face at six months of treatment. The reviewers said that if...Tags: Facial Wrinkles, Wells Fargo & Co., Food and Drug Administration, Stock Market, NYSE Euronext, Inc.
-
Counterfeit wrinkle-filler Botox discovered in the United States
ReutersApril 26 (Reuters) - The U.S. Food and Drug Administration said on Friday that fake versions of Botox, a drug made by Allergan Inc that is used as a wrinkle-filler and for headaches, are being sold in the United States. The FDA said in an alert issued to...Tags: Drugs and Medicines, Botox (drug), Food and Drug Administration
-
FDA warns of fake Botox
ReutersAn alert posted on the Food and Drug Administration website Friday warns consumers that counterfeit versions of Botox are being sold in U.S. The drug, made by Allergan Inc., is used to treat wrinkles, headaches and other conditions. "FDA cannot confirm...Tags: Drugs and Medicines, Botox (drug), Food and Drug Administration, Health Insurance Cost
-
UK review warns on cosmetic injections, urges tougher rules
Reuters* Dermal fillers "a crisis waiting to happen", review says * Call for products to be made prescription only * UK review prompted by PIP breast implant scandal LONDON, April 24 (Reuters) - Cosmetic treatment needs tougher regulation, particularly over...Tags: Government, Politics, Health Organizations, Manufacturing and Engineering, Marketing
-
What California should learn from the 1-800-GET-THIN saga
Today, 19 months after her death, we may finally have a good idea of what killed Paula Rojeski. According to a lawsuit and public autopsy records, the causes included her doing business with the 1-800-GET-THIN folks and the slicing of her aorta during...Tags: Hospitals and Clinics, Justice System, Health Organizations, Ethics, Lawyers
May 10, 2013
|Story| Los Angeles Times
May 7, 2013
|Story| Reuters
May 2, 2013
|Story| Reuters
May 1, 2013
|Story| Chicago Tribune
May 1, 2013
|Story| Reuters
May 1, 2013
|Story| Reuters
May 1, 2013
|Story| Reuters
Apr 30, 2013
|Story| Reuters
Apr 26, 2013
|Story| Reuters
Apr 26, 2013
|Story| Reuters
Apr 24, 2013
|Story| Reuters
Apr 19, 2013
|Column| Los Angeles Times
Original site for Allergan Inc. topic gallery.
